Literature DB >> 857038

Human colon adenocarcinoma cells. II. Tumorigenic and organoid expression in vivo and in vitro.

B H Tom, L P Rutzky, R Oyasu, J T Tomita, D M Goldenberg, B D Kahan.   

Abstract

A human colon epithelial tumor cell line (LS174T) recultured in vitro following passage through hamsters displayed differences in its cell doubling time and synthesis of carcinoembryonic antigen when compared with the cells grown solely in vitro. These animal-passaged cells more closely resembled the parent tumor cell line (LS180) derived from the primary tumor than LS174T, the trypsinized variant of LS180. Analysis of lactate dehydrogenase isoenzymes indicated that the tumor cells recovered from the hamsters were free of xenogeneic host tissue. Furthermore, LS174T grafted to athymic (nude) mice grew as a mucinous adenocarcinoma microscopically resembling the original tumor. The altered growth potential of LS174T was also demonstrated on confluent feeder monolayers of normal cells and by uninhibited multiplication in vitro. These results suggest that, at least in this one case, short-term passage of long-term cultured cells into xenogeneic hosts may effect a phenotypic reversion such that the cells regain properties observed in the primary tumor and the initial in vitro explant.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 857038     DOI: 10.1093/jnci/58.5.1507

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression.

Authors:  Mark B Meyer; Paul D Goetsch; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2011-11-22

2.  Monoclonal antibody to cytokeratin for use in routine histopathology.

Authors:  C A Makin; L G Bobrow; W F Bodmer
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

3.  8-Cl-adenosine induces differentiation in LS174T cells.

Authors:  C C Carlson; L L Burnham; R A Shanks; D T Dransfield
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

4.  Characterization of a human colonic adenocarcinoma cell line, LS123.

Authors:  L P Rutzky; B C Giovanella; B H Tom; C I Kaye; P D Noguchi; B D Kahan
Journal:  In Vitro       Date:  1983-02

5.  Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts.

Authors:  M V Pimm; A C Perkins; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1987

6.  Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes.

Authors:  L Raphael; B H Tom
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

7.  Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenografts.

Authors:  S M Andrew; M V Pimm; A C Perkins; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1986

8.  124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.

Authors:  Peng Zou; Stephen P Povoski; Nathan C Hall; Michelle M Carlton; George H Hinkle; Ronald X Xu; Cathy M Mojzisik; Morgan A Johnson; Michael V Knopp; Edward W Martin; Duxin Sun
Journal:  World J Surg Oncol       Date:  2010-08-06       Impact factor: 2.754

9.  New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.

Authors:  J Tian; Z Y Tang; S L Ye; Y K Liu; Z Y Lin; J Chen; Q Xue
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

10.  Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.

Authors:  Sebastian Korff; Stefan M Woerner; Yan P Yuan; Peer Bork; Magnus von Knebel Doeberitz; Johannes Gebert
Journal:  BMC Cancer       Date:  2008-11-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.